Autor: Heather Scott

  • GBT Pharma’s UK Arm Seals Deal with Creso for cannaQIX UK Launch

    GBT Pharma’s UK Arm Seals Deal with Creso for cannaQIX UK Launch

    GBT Pharma’s UK sister company – Precision Healthcare – has secured a commercialisation deal with Swiss-based Creso Pharma (CPH) to launch the cannaQIX range in the UK.

    The nutraceutical products – cannaQIX 10 and 50 – are a proprietary formulation of full plant organic hemp extract with cannabidiol (CBD), vitamins and zinc.

    Developed as a cognitive booster, cannaQIX helps to maintain mental and nervous function, reduce fatigue and release energy. Its standardised formulation offers a novel delivery system with precise dosage control, enabling a consistent, stable effect over several days. The product is safe, well-tolerated, non-euphoric, non-addictive and sugar-free.

    CannaQIX is the latest addition to Precision Healthcare’s OTC consumer healthcare portfolio. The UK-based, privately-held company was founded in 2014 to support GBT Pharma’s offering in Europe. Covering more than 5000 points of sale in the UK, Precision Healthcare specialises in developing OTC consumer healthcare brands for independent pharmacy, health food channels and key accounts.

    The deal will see Precision Healthcare execute the non-exclusive marketing and distribution of cannaQIX 10 and 50 across pharmacy and health food channels from spring 2018.

    CPH CEO and co-founder, Dr Miri Halperin Wernli comments: «We are delighted to partner with Precision Healthcare and to have obtained the necessary regulatory approvals for cannaQIX in the UK, both significant milestones for our company.»

    Matthew Caldwell-Nichols, CEO of Precision Healthcare added: «We are proud to be working with Creso Pharma in marketing this innovative range of cannabidiol and hemp-based nutraceuticals. We look forward to a successful business partnership as we grow the brand in the UK.»

    To find out more about the cannaQIX range click here.

    Companies interested in finding out more about cannaQIX and other Precision Healthcare brands are invited to contact us. 

  • GBT Pharma founder appointed as Commercial Advisor to Creso Pharma

    GBT Pharma founder appointed as Commercial Advisor to Creso Pharma

    Dr. Gian Trepp, founder of GBT Pharma has been appointed by Creso Pharma as Commercial Advisor.

    Having held worldwide executive leadership positions in General Management and Marketing for global pharmaceutical companies in Switzerland and the US, Gian brings over 18 years of strategic and operational leadership in the pharmaceutical field to the role.

    Creso Pharma is working to develop and produce safe, cannabis- and hemp- derived therapeutic products and treatments for humans and pets. The nutraceutical and medical cannabis company, offers a range of products designed to create better overall health in humans and pets.

    Speaking of his appointment, Gian said: “Cannabidiol (CBD) has shown therapeutic value for various diseases and conditions not least in the treatment of anxiety and stress.

    «The new Cannaqix range from Creso pharma is a full plant hemp-based nutraceutical with an innovative delivery and dosage system and is totally unique in the sector. I am looking forward to working closely with Creso Pharma to bring this ground-breaking product to market in the coming months.”

  • Precision Healthcare breathes new life into children’s inhalation category

    Precision Healthcare breathes new life into children’s inhalation category

    Consumer healthcare specialists and GBT Pharma’s sister company in the UK – Precision Healthcare – is reinvigorating the children’s inhalation category with the launch of Klear-vol, a range of capsules developed with the natural vapours of essential oils for both day and night time use.

    Perfect for when the whole family needs to get a good night’s rest, Klear-vol is a new range of soothing inhalation vapour capsules for children containing aromas of natural pine, thymol and menthol

    Suitable for both day and night time use, and from age 3 months upwards, Klear-vol combines a complimentary blend of beneficial aromatic extracts including natural pine, thymol and menthol oils all encapsulated in soft gelatin capsules.

    When released these vapours provide long-lasting comfort over several hours, so parents can worry less and everyone can get a better night’s rest.

    Application, simply follow these steps:

    Step 1. Carefully cut off the top of the capsule with a pair of scissors
    Step 2. Ensure the tip is pointing downwards and away from the face
    Step 3. Pour the liquid contents onto a cloth, handkerchief or tissue
    Step 4. Ensure the cloth used is secured and completely out of reach of the child

    Klear-Vol is available now from Boots www.boots.com independent health food stores and pharmacies and www.herbal-direct.com.

    For more information visit: www.klear-vol.com or contact Precision Healthcare